AiMeD gives Emotional Send Off to DoP Secy Dr Vaghela

New Delhi: Association of Indian Medical Device Industry (AiMeD) says it owes outgoing DoP Secy Dr PD Vaghela big time for the leg up he contributed to the indutry. In an emotional send off, the industry body profusely lauded his contribution towards betterment of Indian Medical Device Industry. IAS officer Dr PD Vaghela will now serve as TRAI chief for three years.

Dr Vaghela retired on September 30, 2020 as Secretary in the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers after his illustrious career in government. AiMeD, an umbrella association of Indian manufacturers of medical devices, covering all types of medical devices held a farewell meeting to express its indebtedness to him for what he did to promote Indian Medical Device.

Calling Dr. PD Vaghela a positive change agent in the one year that he headed as Secy DoP, Mr. Rajiv Nath, Forum Coordinator AiMeD, representing interest of over 1200 medical device manufacturers highlighted the key initiatives lead by Dr. Vaghela.

During his tenure DoP sponsored 2 conferences for AiMeD on Regulations for enabling capacity building of the medical devices industry to enable them to be globally competitive. Dr. Vaghela initiated a 5% surcharge in budget as import duty protection to protect the beleaguered domestic Manufacturing while creating corpus for Public Healthcare. He did not allow price caps of stents & knee implants to be removed as sought by USA as that would have been detrimental to consumers and domestic manufacturers. Under his leadership DoP introduced a scheme for 4 Medical Devices Parks & PLI scheme as a make in India enablers under the Govt.’s Atmanirbhar campaign; the PLI Scheme is reportedly being revised to enable wider acceptability.

Mr. Vaghela lead by example and he along with his 2 Jt.Secy and team was available 24×7 on Covid related medical devices production debottlenecking issues during complete lockdown.

He also created Pharma & Medical Devices Bureau as a single window for current and potential investors. The otherwise sleepy DoP Dept. reportedly became motivated, active & sprightly & most staff moved under a new Pharma bureau in new offices in Jhandewalan. He even allocated specific duties in Dept. for Medical Devices which had been shunted in past amongst various officers for short durations without development of domain knowledge and ownership in the department. DrVaghela reportedly encouraged teamwork by providing leadership & direction. Even NPPA became facilitator in addition to being a regulator with onset of Covid.

Although the Indian Medical Device & Pharma industry is disappointed that the dynamic Dr. PD Vaghela departs from Dept. of Pharma on Sep 30th 2020 for his next career assignment as Chairman TRAI, various pharma& medical devices industry associations expressed their gratitude and wished him good luck and success in his future endeavors. They were hopeful that the next Secretary DoPS Aparna, an IAS officer from the Gujarat cadre 1988 will continue to take forward the good initiatives to make India Atmanirbhar in Medical Devices sector.

India imports over 85% of its requirement of medical devices and has a huge imports bill that crossed Rs. 42000 Cr last year due to nominal custom duties of zero to 7.5%.“We are glad that initiatives like Aatmanirbhar Bharat under leaders like Dr Vaghela will help India in the process to end the huge import dependency and will also strengthen India’s resolve to vie for being the 2nd factory in world for Medical Devices.” added Mr. Rajiv Nath.

Related Posts

Pain is passé in Blood Test, thanks to Metropolis’ Human Touch

New Delhi: Blood drawing for test has really reached proverbial ant bite, thanks to introduction of innovative blood collection technology by Metropolis healthcare, India’s second largest pathology laboratory chain. First…

60 Countries witnessed AMTZ, Seed of Global Hub of Medical Devices

Vishakhapatnam: It could be the beginning of the end of dependence of India on imports of medical devices. Import lobby must have watched this gathering of 60 countries to witness…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

India-Latin America trade and collaboration prospects discussed at Kerala University conference

India-Latin America trade and collaboration prospects discussed at Kerala University conference

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt